Cas:104051-20-9 6-[1-hydroxy-2-[(2-methyl-4-phenylbutan-2-yl)amino]ethyl]-3,4-dihydro-1H-quinolin-2-one manufacturer & supplier

Chemical Name:6-[1-hydroxy-2-[(2-methyl-4-phenylbutan-2-yl)amino]ethyl]-3,4-dihydro-1H-quinolin-2-one

CAS.NO:104051-20-9

Synonyms:Brefonalol [INN];Brefonalolum;Brefanolol;Brefonalol;Brefonalolum [Latin];UNII-DVO6SSG9S3

Molecular Formula:C₂₂H₂₈N₂O₂

Molecular Weight:352.47000

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:578.8ºC at 760mmHg

Density:1.129g/cm3

Index of Refraction:1.582

PSA:61.36000

Exact Mass:352.21500

LogP:4.13460

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Brefonalol [INN] chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,UNII-DVO6SSG9S3 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Brefonalolum Use and application,Brefonalol technical grade,usp/ep/jp grade.

Related News: Any South Korean citizen returning home who has been in Hubei Province within the past two weeks will be subject to 14 days of self-quarantine and monitoring, the government said. 6-[1-hydroxy-2-[(2-methyl-4-phenylbutan-2-yl)amino]ethyl]-3,4-dihydro-1H-quinolin-2-one manufacturer ��We believe such actions are our last resort,�� the Hospital Authority Employees Alliance, a union that formed during the city��s antigovernment protest movement, wrote in a statement. 6-[1-hydroxy-2-[(2-methyl-4-phenylbutan-2-yl)amino]ethyl]-3,4-dihydro-1H-quinolin-2-one supplier Any South Korean citizen returning home who has been in Hubei Province within the past two weeks will be subject to 14 days of self-quarantine and monitoring, the government said. 6-[1-hydroxy-2-[(2-methyl-4-phenylbutan-2-yl)amino]ethyl]-3,4-dihydro-1H-quinolin-2-one vendor ��We believe such actions are our last resort,�� the Hospital Authority Employees Alliance, a union that formed during the city��s antigovernment protest movement, wrote in a statement. 6-[1-hydroxy-2-[(2-methyl-4-phenylbutan-2-yl)amino]ethyl]-3,4-dihydro-1H-quinolin-2-one factory However, the study did not produce any significant benefits when it came to thinking, reasoning and memory tests performed across the entire patient group — possibly because there were too few people with clinically diagnosed Alzheimer’s participating in the trial.